FLASH Radiotherapy: Mechanisms of Biological Effects and the Therapeutic Potential in Cancer
-
Published:2024-06-25
Issue:7
Volume:14
Page:754
-
ISSN:2218-273X
-
Container-title:Biomolecules
-
language:en
-
Short-container-title:Biomolecules
Author:
Yan Ouying1, Wang Shang1, Wang Qiaoli1, Wang Xin1
Affiliation:
1. Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, Cancer Center, West China Hospital of Sichuan University, Chengdu 610041, China
Abstract
Radiotherapy is an important treatment for many unresectable advanced malignant tumors, and radiotherapy-associated inflammatory reactions to radiation and other toxic side effects are significant reasons which reduce the quality of life and survival of patients. FLASH-radiotherapy (FLASH-RT), a prominent topic in recent radiation therapy research, is an ultra-high dose rate treatment known for significantly reducing therapy time while effectively targeting tumors. This approach minimizes radiation side effects on at-risk organs and maximally protects surrounding healthy tissues. Despite decades of preclinical exploration and some notable achievements, the mechanisms behind FLASH effects remain debated. Standardization is still required for the type of FLASH-RT rays and dose patterns. This review addresses the current state of FLASH-RT research, summarizing the biological mechanisms behind the FLASH effect. Additionally, it examines the impact of FLASH-RT on immune cells, cytokines, and the tumor immune microenvironment. Lastly, this review will discuss beam characteristics, potential clinical applications, and the relevance and applicability of FLASH-RT in treating advanced cancers.
Funder
National Natural Science Foundation of China Sichuan Science and Technology Support Project 1·3·5 Project for Disciplines of Excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University
Reference97 articles.
1. Hepatocellular carcinoma;Vogel;Lancet,2022 2. Advances in resection and transplantation for hepatocellular carcinoma;Vibert;J. Hepatol.,2020 3. Hepatocellular carcinoma review: Current treatment, and evidence-based medicine;Karaman;World J. Gastroenterol.,2014 4. D’Amours, M.F., Wu, F.T.H., Theisen-Lauk, O., Chan, E.K., McGuire, A., and Ho, C. (Eur. Respir. J., 2024). Surgically Resectable Non-Small Cell Lung Cancer: A Contemporary Approach, Eur. Respir. J., in press. 5. Yu, H., Yang, Z., Zhang, Z., Wang, T., Ran, M., Wang, Z., Liu, L., Liu, Y., and Zhang, Y. (2024). Multiple organ segmentation framework for brain metastasis radiotherapy. Comput. Biol. Med., 177.
|
|